Purple Biotech Ltd. (PPBT)

Purple Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cost of Revenue	0.2	0.2	0.12	0.06	0.06	0.08
Gross Profit	-0.2	-0.2	-0.12	-0.06	-0.06	-0.08
Selling, General & Admin	4.46	5.04	6.03	6.04	5.9	3.96
Research & Development	16.96	17.03	16.32	11.83	7.24	2.28
Operating Expenses	21.42	22.08	22.35	17.87	13.14	6.24
Operating Income	-21.62	-22.27	-22.47	-17.92	-13.2	-6.32
Interest & Investment Income	0.94	0.47	0.53	0.32	0.25	0.15
Currency Exchange Gain (Loss)	-0.01	-0.01	0.06	-0.13	-0.01	-0.1
Other Non Operating Income (Expenses)	1.83	1.83	0.25	-0.08	-15.71	1.43
EBT Excluding Unusual Items	-18.86	-19.98	-21.63	-17.81	-28.66	-4.84
Legal Settlements	-	-	-0.14	-0.01	-0.04	-0.36
Pretax Income	-18.86	-19.98	-21.76	-17.83	-28.7	-5.19
Income Tax Expense	-	-	-	-	-	0.22
Earnings From Continuing Operations	-18.86	-19.98	-21.76	-17.83	-28.7	-5.41
Earnings From Discontinued Operations	-	-	-	-0.64	0.63	-0.49
Net Income to Company	-18.86	-19.98	-21.76	-18.47	-28.07	-5.89
Minority Interest in Earnings	0.09	0.1	0.09	0.08	0.08	0.04
Net Income	-18.76	-19.88	-21.67	-18.38	-28	-5.85
Net Income to Common	-18.76	-19.88	-21.67	-18.38	-28	-5.85
Shares Outstanding (Basic)	223	221	181	176	115	19
Shares Outstanding (Diluted)	223	221	181	176	115	19
Shares Change (YoY)	20.05%	22.41%	2.92%	52.76%	493.78%	36.34%
EPS (Basic)	-0.08	-0.09	-0.12	-0.10	-0.24	-0.30
EPS (Diluted)	-0.08	-0.09	-0.12	-0.10	-0.24	-0.30
Free Cash Flow	-18.94	-19.93	-16.76	-15.37	-12.25	-5.59
Free Cash Flow Per Share	-0.08	-0.09	-0.09	-0.09	-0.11	-0.29
EBITDA	-21.57	-22.23	-22.42	-17.69	-12.96	-6.14
D&A For EBITDA	0.05	0.05	0.05	0.23	0.24	0.18
EBIT	-21.62	-22.27	-22.47	-17.92	-13.2	-6.32

Source: S&P Capital IQ. Standard template.